Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series.

Alexander T GalloStephen AddisVlad MartynHishani RamanathanGrace K Wilkerson Sean D HoodHans StampferGary K Hulse

Published in: Behavioral sciences (Basel, Switzerland) (2022)

Data suggest that low-dose continuous flumazenil infusion manages GAD symptoms and is safe. Although these results are promising, future randomised control trials are required to confirm these results.

Keyphrases

low dose
high dose
clinical trial
open label
electronic health record
current status
study protocol
double blind
big data
randomized controlled trial